Age-at-onset Modifiers
Age-At-Onset Modifiers is a genetic or environmental factor that belongs to the class of phenotypic modifiers and specifically influences the timing of symptom manifestation in neurodegenerative diseases without altering the primary disease-causing mutation.
65
Publications
3.3K
Citations
1.6K
Authors
430
Institutions
Publications per year
2017–2026
15
65
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion
J.-M. Lee, E.M. Ramos, J.-H. Lee et al. · Neurology · 2012 · 391 citations · Full text
Life Sciences, Genetics, Neurology +15
Fernando Morales, Jillian M. Couto, Catherine F. Higham et al. · Human Molecular Genetics · 2012 · 181 citations · Full text
The clinical and screening age-at-onset distribution for the MEN-2 syndrome.
Douglas F. Easton, Margaret A. Ponder, T.S. Cummings et al. · PubMed · 1989 · 109 citations
1–5 of 65
1.6K
5
h-index
4
h-index
4
h-index
4
h-index
4
h-index
1–5 of 1.6K
430
Massachusetts General Hospital
Boston, United States
6 h-index
38 publications
5.3K citations
Inserm
Paris, France
6 h-index
87 publications
4.3K citations
Harvard University
Cambridge, United States
5 h-index
16 publications
1.1K citations
Assistance Publique – Hôpitaux de Paris
Paris, France
5 h-index
36 publications
1.7K citations

Universidade do Porto
Porto, Portugal
5 h-index
30 publications
3.8K citations

University of Toronto
Toronto, Canada
5 h-index
41 publications
4.6K citations
Universidad de Antioquia
Medellín, Colombia
5 h-index
33 publications
1.8K citations
University College London
London, United Kingdom
5 h-index
54 publications
14.5K citations
1–8 of 430
5 publications · 460 citations
5
h-index
4 publications · 162 citations
4
h-index
3 publications · 92 citations
3
h-index
2 publications · 417 citations
2
h-index
2 publications · 154 citations
2
h-index
1–5